Vitro Diagnostics, Inc.
Vitro Launches Products to Support Stem Cell Research and Drug Development
Published in Healthcare Mergers, Acquisitions and Ventures Week, June 6th, 2009
Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced the commercial availability of specialized products to support stem cell research and drug development. This new product line called, “Tools for Stem Cell and Drug Development™” features novel products to support research involving mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPS) and cancer research that specifically utilizes stem cells that preferentially migrate to cancer cells and facilitate their destruction. Vitro Diagnostic’s newly revised website, www.vitrobiopharma.com, details our new products. The current total market for stem cell research tools is estimated to be about $900 million and is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 100 Black Men of America, Inc.
U.S. Secretary of Education Arne Duncan, New York Gov. David Paterson to Speak at 23rd Annual 100 Black Men of America Conference in New York City, June 10th-14th - 192.com
Free International Phonebook Directory Launched - 20-First
Banks Must Have More Women at the Top to Avoid Another Crisis - 3 Greek Gods LLC
The Greek Gods Yogurt Soars Domestically with Euro-Style Dairy Products - 360networks
360networks Continues to Provide VoIP Services to Rural Areas with the Addition of South Dakota - 3M
New 3M Dynatel Modular Test Set Extends xDSL Measurement Range to 30 MHz - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
